| 1 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
ARID1A |
| 2 |
34560683 |
10.1097/PAS.0000000000001813 |
2022 |
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. |
ARID1A |
| 3 |
34649275 |
10.1182/bloodadvances.2021005316 |
2022 |
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity. |
ARID1A |
| 4 |
34791836 |
10.1002/cam4.4422 |
2022 |
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. |
ARID1A |
| 5 |
35038193 |
10.1111/his.14617 |
2022 |
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. |
ARID1A |
| 6 |
35054466 |
10.3390/life12010073 |
2022 |
The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma. |
ARID1A |
| 7 |
35172382 |
10.1002/JLB.5A0721-361R |
2022 |
Genomic heterogeneity contributed to different prognosis between adult and pediatric acute lymphoblastic. |
ARID1A |
| 8 |
35317330 |
10.14740/wjon1436 |
2022 |
Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. |
ARID1A |
| 9 |
35454811 |
10.3390/cancers14081904 |
2022 |
Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. |
ARID1A |
| 10 |
35727053 |
10.1002/cncr.34348 |
2022 |
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. |
ARID1A |
| 11 |
35794096 |
10.1038/s41467-022-31355-8 |
2022 |
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. |
ARID1A |
| 12 |
35879731 |
10.1186/s40364-022-00401-4 |
2022 |
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma. |
ARID1A |
| 13 |
36001451 |
10.1097/PAS.0000000000001956 |
2022 |
Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas. |
ARID1A |
| 14 |
33431788 |
10.1038/s41392-020-00437-8 |
2021 |
CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. |
ARID1A |
| 15 |
33829512 |
10.1111/his.14378 |
2021 |
Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma. |
ARID1A |
| 16 |
34039950 |
10.1038/s41408-021-00493-5 |
2021 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
ARID1A |
| 17 |
34070951 |
10.3390/diagnostics11060999 |
2021 |
Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma. |
ARID1A |
| 18 |
34348985 |
10.1136/jclinpath-2021-207441 |
2021 |
Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours. |
ARID1A |
| 19 |
31423576 |
10.1111/bjh.16159 |
2020 |
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy. |
ARID1A |
| 20 |
32083995 |
10.1200/JCO.19.02314 |
2020 |
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies. |
ARID1A |
| 21 |
32918521 |
10.1002/pbc.28704 |
2020 |
Aggressive Langerhans cell histiocytosis following T-cell acute lymphoblastic leukemia. |
ARID1A |
| 22 |
32978169 |
10.1158/0008-5472.CAN-20-2147 |
2020 |
EZH2-Targeted Therapies in Cancer: Hype or a Reality. |
ARID1A |
| 23 |
33252851 |
10.1002/ctm2.221 |
2020 |
Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. |
ARID1A |
| 24 |
33376237 |
10.1038/s41392-020-00331-3 |
2020 |
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma. |
ARID1A |
| 25 |
30886885 |
10.1016/j.gore.2019.02.007 |
2019 |
Endometrial cancer arising after complete remission of uterine malignant lymphoma: A case report and mutation analysis. |
ARID1A |
| 26 |
31123138 |
10.1136/jclinpath-2019-205727 |
2019 |
Intravascular NK/T-cell lymphoma: clinicopathological and integrated molecular analysis of two cases provides a clue to disease pathogenesis. |
ARID1A |
| 27 |
31300419 |
10.1182/bloodadvances.2018029546 |
2019 |
Sporadic and endemic Burkitt lymphoma have frequent <i>FOXO1</i> mutations but distinct hotspots in the AKT recognition motif. |
ARID1A |
| 28 |
31747604 |
10.1016/j.celrep.2019.10.083 |
2019 |
Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas. |
ARID1A |
| 29 |
29307627 |
10.1016/j.humpath.2017.12.025 |
2018 |
Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant. |
ARID1A |
| 30 |
29486633 |
10.1177/1533034618754475 |
2018 |
Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma. |
ARID1A |
| 31 |
29669287 |
10.1016/j.celrep.2018.03.078 |
2018 |
ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer. |
ARID1A |
| 32 |
29989027 |
10.18632/oncotarget.25601 |
2018 |
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. |
ARID1A |
| 33 |
30134235 |
10.1159/000492835 |
2018 |
Frequent Mutations in Natural Killer/T Cell Lymphoma. |
ARID1A |
| 34 |
30190015 |
10.1016/j.hoc.2018.05.007 |
2018 |
Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia: C-X-C Chemokine Receptor Type 4 Mutation and Beyond. |
ARID1A |
| 35 |
27872090 |
10.1158/0008-5472.CAN-16-1303 |
2017 |
Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia. |
ARID1A |
| 36 |
28401006 |
|
2017 |
Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors. |
ARID1A |
| 37 |
29025291 |
10.1556/650.2017.30868 |
2017 |
[Waldenström's macroglobulinemia and its individualized therapy options]. |
ARID1A |
| 38 |
29222279 |
10.1182/asheducation-2017.1.358 |
2017 |
Follicular lymphoma: are we ready for a risk-adapted approach? |
ARID1A |
| 39 |
26839360 |
10.1136/thoraxjnl-2015-207950 |
2016 |
A patient with complex multiple genomic ALK alterations. |
ARID1A |
| 40 |
27102345 |
10.1038/modpathol.2016.79 |
2016 |
Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies. |
ARID1A |
| 41 |
27590521 |
10.18632/oncotarget.11773 |
2016 |
Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes. |
ARID1A |
| 42 |
27729836 |
10.5808/GI.2016.14.3.78 |
2016 |
Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel. |
ARID1A |
| 43 |
25444907 |
10.1016/j.canlet.2014.11.024 |
2015 |
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. |
ARID1A |
| 44 |
25779943 |
10.1158/1078-0432.CCR-14-2759 |
2015 |
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing. |
ARID1A |
| 45 |
25918285 |
10.1200/JCO.2014.59.2444 |
2015 |
Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing. |
ARID1A |
| 46 |
26192917 |
10.1038/ng.3358 |
2015 |
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma. |
ARID1A |
| 47 |
26256760 |
10.1016/S1470-2045(15)00169-2 |
2015 |
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. |
ARID1A |
| 48 |
26415585 |
10.1038/ncomms9470 |
2015 |
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome. |
ARID1A |
| 49 |
26446488 |
10.1038/ncomms9325 |
2015 |
LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. |
ARID1A |
| 50 |
26468873 |
10.1371/journal.ppat.1005158 |
2015 |
Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. |
ARID1A |
| 51 |
26473533 |
10.1038/bcj.2015.89 |
2015 |
Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas. |
ARID1A |
| 52 |
26551670 |
10.1038/ng.3444 |
2015 |
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes. |
ARID1A |
| 53 |
24366360 |
10.1182/blood-2013-09-525808 |
2014 |
The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. |
ARID1A |
| 54 |
24435047 |
10.1182/blood-2013-05-500264 |
2014 |
Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. |
ARID1A |
| 55 |
23292937 |
10.1073/pnas.1205299110 |
2013 |
Genetic heterogeneity of diffuse large B-cell lymphoma. |
ARID1A |
| 56 |
22585168 |
10.1158/2159-8290.CD-11-0208 |
2012 |
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. |
ARID1A |
| 57 |
22915242 |
10.1007/s00428-012-1303-2 |
2012 |
ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability. |
ARID1A |
| 58 |
22931316 |
10.1056/NEJMoa1200710 |
2012 |
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. |
ARID1A |
| 59 |
23091298 |
10.1182/blood-2012-06-437624 |
2012 |
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. |
ARID1A |
| 60 |
23143597 |
10.1038/ng.2468 |
2012 |
The genetic landscape of mutations in Burkitt lymphoma. |
ARID1A |
| 61 |
21590771 |
10.1002/path.2911 |
2011 |
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. |
ARID1A |
| 62 |
19066270 |
10.1093/jnci/djn416 |
2008 |
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia. |
ARID1A |
Datasets
Models
